PMC:7247521 / 37901-38544 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"626","span":{"begin":74,"end":82},"obj":"Disease"},{"id":"627","span":{"begin":324,"end":327},"obj":"Disease"}],"attributes":[{"id":"A626","pred":"tao:has_database_id","subj":"626","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Fig. 11 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T578","span":{"begin":74,"end":82},"obj":"SP_7"},{"id":"T579","span":{"begin":118,"end":122},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T580","span":{"begin":245,"end":249},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"Fig. 11 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T71","span":{"begin":74,"end":82},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Fig. 11 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T326","span":{"begin":5,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T327","span":{"begin":152,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T328","span":{"begin":192,"end":196},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Fig. 11 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T322","span":{"begin":118,"end":122},"obj":"Chemical"},{"id":"T323","span":{"begin":245,"end":249},"obj":"Chemical"}],"attributes":[{"id":"A322","pred":"chebi_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A323","pred":"chebi_id","subj":"T323","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Fig. 11 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T279","span":{"begin":0,"end":91},"obj":"Sentence"},{"id":"T280","span":{"begin":92,"end":197},"obj":"Sentence"},{"id":"T281","span":{"begin":198,"end":278},"obj":"Sentence"},{"id":"T282","span":{"begin":279,"end":356},"obj":"Sentence"},{"id":"T283","span":{"begin":357,"end":364},"obj":"Sentence"},{"id":"T284","span":{"begin":365,"end":643},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Fig. 11 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}